Skip to content
LinusBio Wins 2024 BioTech Breakthrough Award for “Overall MedTech Company of the Year”
LinusBio Raises $16 Million to Scale Growth and Deliver Tangible Outcomes
Novozymes and LinusBio announce collaboration to accelerate scientific discovery in Biohealth
LinusBio Recognized at the 2022 Mount Sinai Innovation Awards
WATCH: Detecting Autism at Birth and Opportunity for Early Intervention
Linus Biotechnology Inc. Receives FDA Breakthrough Device Designation for StrandDx™-ASD Exposome Sequencing Diagnostic
Mount Sinai Spin-Off Linus Biotechnology Inc. to Revolutionize Precision Medicine with Exposome Sequencing